Events

Stay informed about how NOCITA® (bupivacaine liposome injectable suspension) can help your patients.

Conferences

Find NOCITA at an Aratana booth during these upcoming conferences.

VMX 2018

At VMX, formerly known as NAVC Conference, Aratana hosted a half-day symposium showcasing NOCITA® (bupivacaine liposome injectable suspension), a long-acting local anesthetic that provides up to 72 hours of post-operative pain control following CCL surgery in dogs.

 

On Monday, February 5, Aratana held an educational CE session (8:00 -9:15 a.m.) featuring an interactive roundtable discussion with Kristin Kirkby-Shaw, DVM, MS, PhD, DACVS, DACVSMR, Mark Epstein, DVM, DABVP (Canine and Feline) and Tamara Grubb, DVM, PhD, DACVAA. The panel detailed how they have successfully incorporated NOCITA into their practice protocols and take questions from session attendees.

 

Aratana also hosted a NOCITA lunch session for Veterinary Technicians (11:00 -12:30 p.m.) on Tuesday, February 6. Donna Sisak, CVT, LVT, VTS (Anesthesia) presented how NOCITA has helped her achieve a smooth and effective post-operative recovery.

 

VMX Conference Link >

WVC 2018

Aratana continued to showcase NOCITA® (bupivacaine liposome injectable suspension), a long-acting local anesthetic that provides up to 72 hours of pain control following CCL surgery in dogs, at the Western Veterinary Conference (WVC) in Las Vegas.

 

Aratana held another educational CE session (10:00 -10:50 p.m.) on Monday, March 5 with Duncan Lascelles, BVSc, PhD, MRCVS, CertVA, DSAS(ST), DACVS, Kristin Kirkby-Shaw, DVM, MS, PhD, DACVS, DACVSMR and Mark Epstein, DVM, DABVP (Canine and Feline) participating in an interactive roundtable discussion on NOCITA, specifically detailing how they have successfully incorporated the long-acting local analgesic into their practice protocols.

 

WVC Conference Link >

VOS 2018

As a key sponsor, Aratana featured NOCITA® (bupivacaine liposome injectable suspension), a long-acting local anesthetic that provides up to 72 hours of pain control following CCL surgery in dogs at Veterinary Orthopedic Society (VOS) in Snowmass Village on Saturday, March 10 through Saturday, March 17.

 

VOS Conference Link >

DOG INDICATION: For single-dose infiltration into the surgical site to provide local post-operative analgesia for cranial cruciate ligament surgery in dogs.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for local infiltration injection in dogs only. Do not use in dogs younger than 5 months of age, that are pregnant, lactating or intended for breeding. Do not administer by intravenous or intra‐arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.

Other therapeutics from Aratana

 

ENTYCE logo

 

Finally, appetite stimulation is in your control.

 

ENTYCE® (capromorelin oral solution) is the ONLY FDA-approved veterinary therapeutic designed to safely and effectively stimulate appetite in dogs. Administered orally once a day, ENTYCE is appropriate for treating inappetence caused by chronic and acute conditions.

VIEW WEBSITE

IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.